Parallel Advisors LLC Buys 346 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)
Parallel Advisors LLC increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 0.9% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 40,902 shares of the exchange traded fund’s stock after purchasing an additional 346 shares during the quarter. […]
More Stories
MetisDAO (METIS) Price Tops $45.53 on Major Exchanges
MetisDAO (METIS) traded up 1.6% against the US dollar during the twenty-four hour period ending at 18:00 PM E.T. on...
PTC (NASDAQ:PTC) versus Mobile-health Network Solutions (NASDAQ:MNDR) Critical Comparison
Mobile-health Network Solutions (NASDAQ:MNDR – Get Free Report) and PTC (NASDAQ:PTC – Get Free Report) are both medical companies, but...
Enegra (EGX) Trading 0.2% Higher This Week (EGX)
Enegra (EGX) (EGX) traded 0.1% higher against the US dollar during the 1-day period ending at 18:00 PM E.T. on...
Viper Networks (OTCMKTS:VPER) & Resources Connection (NASDAQ:RGP) Financial Analysis
Resources Connection (NASDAQ:RGP – Get Free Report) and Viper Networks (OTCMKTS:VPER – Get Free Report) are both small-cap business services...
PAAL AI Achieves Self Reported Market Capitalization of $173.31 Million (PAAL)
PAAL AI (PAAL) traded 3.8% lower against the U.S. dollar during the twenty-four hour period ending at 18:00 PM Eastern...
Morpheus.Network (MNW) Self Reported Market Capitalization Hits $18.16 Million
Morpheus.Network (MNW) traded 8% higher against the dollar during the twenty-four hour period ending at 18:00 PM E.T. on October...